Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 1, 2022 | Series F | $43M | 1 | — | — | Detail |
Sep 12, 2018 | Series E | $52M | 1 | — | — | Detail |
Apr 28, 2017 | Series D | $40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
LabCorp | — | Series F |
Altos Capital Partners | — | Series E |